Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

[Developments and perspectives in radioablative techniques].

T F Jakobs1, R-T Hoffmann, K Tatsch

  • 1Institut für Klinische Radiologie, Klinikum Grosshadern der Ludwig-Maximilians-Universität München, Marchioninistrasse 15, 81377, München, Deutschland. tobias.jakobs@med.uni-muenchen.de

Der Radiologe
|October 19, 2007
PubMed
Summary
This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Preliminary results of intracranial aneurysm treatment with derivo2heal embolization device.

Neuroradiology·2024
Same author

Basilar artery occlusion: drip-and-ship versus direct-to-center for mechanical thrombectomy within the Neurovascular Network of Southwest Bavaria (NEVAS).

Journal of neurology·2023
Same author

Correction to: Prognostic Factors in Overall Survival of Patients with Unresectable Intrahepatic Cholangiocarcinoma Treated by Means of Yttrium-90 Radioembolization: Results in Therapy-Naïve Patients.

Cardiovascular and interventional radiology·2018
Same author

Prognostic Factors in Overall Survival of Patients with Unresectable Intrahepatic Cholangiocarcinoma Treated by Means of Yttrium-90 Radioembolization: Results in Therapy-Naïve Patients.

Cardiovascular and interventional radiology·2018
Same author

Accurate differentiation of parkinsonism and essential tremor using visual assessment of [<sup>123</sup> I]-FP-CIT SPECT imaging: The [<sup>123</sup> I]-FP-CIT study group.

Movement disorders : official journal of the Movement Disorder Society·2017
Same author

Automatic path proposal computation for CT-guided percutaneous liver biopsy.

International journal of computer assisted radiology and surgery·2016
Same journal

Der Radiologe·2024
Same journal

Der Radiologe·2024
Same journal

Der Radiologe·2024
Same journal

Der Radiologe·2024
Same journal

Der Radiologe·2022
Same journal

Der Radiologe·2022
See all related articles

Radioembolization shows promise for liver cancers and colorectal metastases. Further research is needed to compare (90)Yttrium radioembolization with other treatments and assess quality of life.

Area of Science:

  • Oncology
  • Radiology
  • Hepatobiliary Medicine

Background:

  • Radioembolization with (90)Yttrium microspheres demonstrates encouraging preliminary results in hepatocellular carcinoma and colorectal liver metastases.
  • This suggests potential efficacy in treating breast and neuroendocrine metastases originating from colorectal cancer.

Purpose of the Study:

  • To explore the potential of (90)Yttrium radioembolization in combinatorial therapy regimens with radiosensitizers and growth factor inhibitors.
  • To identify the need for further randomized trials comparing (90)Yttrium radioembolization against alternative treatments for hepatocellular carcinoma.
  • To investigate the quality of life outcomes in patients undergoing radioembolization compared to systemic chemotherapy.

Main Methods:

  • Review of preliminary results and existing literature on radioembolization therapy.

Related Experiment Videos

  • Identification of research gaps and future directions for clinical trials.
  • Focus on comparative effectiveness research and quality of life assessments.

    • Main Results:

    • Preliminary data suggest radioembolization is a viable option for hepatocellular carcinoma and colorectal liver metastases.
    • Combinatorial approaches using (90)Yttrium microspheres with other agents present new therapeutic opportunities.
    • Significant need for randomized controlled trials to establish optimal treatment pathways and comparative efficacy.

    Conclusions:

    • Radioembolization, particularly with (90)Yttrium, holds promise for various liver malignancies and metastases.
    • Further rigorous research, including randomized trials, is essential to define its role and optimize patient outcomes.
    • Quality of life assessment should be integrated into future comparative studies to provide a comprehensive evaluation of treatment benefits.